Information  X 
Enter a valid email address

Sativa Wellness (SWEL)

  Print   

Wednesday 21 April, 2021

Sativa Wellness

Laboratory achieves ISO17025 Accreditation

RNS Number : 0949W
Sativa Wellness Group Inc.
21 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Sativa Wellness Group Inc.
("Sativa" or "Sativa Wellness" the "Company" or the "Group")

21 April 2021

 

Sativa Wellness Groups Laboratory achieves ISO17025 Accreditation

 

 

Sativa Wellness Group is pleased to announce that the Company's subsidiary PhytoVista Laboratories has been granted accreditation to ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories.

Accreditation for the testing of cannabinoids has been granted by United Kingdom Accreditation Service (UKAS), the UK governments appointed National Accreditation Body.  The accreditation process determines the technical competence and integrity of organisations such as those offering testing services.

ISO17025 accreditation offers the Company a competitive advantage in regulated markets where organisations are required to test with an accredited laboratory.  This development also positions the Company well to take advantage of a growing international market and developing regulatory landscape.  The Company plans to increase the scope of testing covered by accreditation and penetrate other areas of testing, whilst continuing to develop and expand cannabinoid testing capabilities.

The Company is in the process of extending the Phytovista testing services to its laboratory in Poland to service Europe, and as part of that process it intends to implement the ISO17025 standard there.

Geremy Thomas Executive Chairman says: "This success supports the direction of the Sativa Wellness Group to be the gold standard in the testing industry, driving growth through providing trusted services".

The Directors of the Company accept responsibility for the contents of this announcement.

On behalf of the Board of Directors,

 

Geremy Thomas

Executive Chairman

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

[email protected]

 www.sativawellnessgroup.com

Anne Tew

Corporate Secretary

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

[email protected]

 www.sativawellnessgroup.com

 

 

 

 

AQSE Growth Market Corporate Adviser

Peterhouse Capital Limited

Guy Miller/Allie Feuerlein

+ 44 (0) 20 7220 9795 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFZGZDLGMGMZM

a d v e r t i s e m e n t